--- title: "Acadia Healthcare | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 828.8 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/284647404.md" datetime: "2026-04-29T21:24:58.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284647404.md) - [en](https://longbridge.com/en/news/284647404.md) - [zh-HK](https://longbridge.com/zh-HK/news/284647404.md) --- # Acadia Healthcare | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 828.8 M Revenue: As of FY2026 Q1, the actual value is USD 828.8 M, beating the estimate of USD 823.54 M. EPS: As of FY2026 Q1, the actual value is USD 0.05, missing the estimate of USD 0.266. EBIT: As of FY2026 Q1, the actual value is USD 49.29 M. #### Segment Revenue - **Acute Inpatient Psychiatric Facilities:** $471 million for Q1 2026, an increase of 14% from $412 million for Q1 2025 . - **Specialty Treatment Facilities:** $128 million for Q1 2026, a decrease of -7% from $137 million for Q1 2025 . - **Comprehensive Treatment Facilities:** $140 million for Q1 2026, an increase of 2% from $137 million for Q1 2025 . - **Residential Treatment Facilities:** $90 million for Q1 2026, an increase of 6% from $85 million for Q1 2025 . - **Total Revenue:** $829 million for Q1 2026 compared to $771 million for Q1 2025, an 8% increase . #### Operational Metrics - **Net Income Attributable to Acadia Healthcare Company, Inc.:** $4.105 million for Q1 2026 compared to $8.374 million for Q1 2025 . - **Adjusted Net Income Attributable to Acadia Healthcare Company, Inc.:** $33.323 million for Q1 2026 compared to $36.929 million for Q1 2025 . - **Adjusted EBITDA:** $144.2 million for Q1 2026 compared to $134.2 million for Q1 2025, representing a 7% increase . Adjusted EBITDA for Q1 2026 was favorably impacted by $3.2 million less in benefit expenses . - **Total Operating Expenses:** $684.6 million for Q1 2026, an increase of $48.3 million or 7.6% over Q1 2025 . This included a $10.3 million increase for PLGL costs reserve and a $6.0 million increase in provider taxes . - **Salaries, Wages and Benefits:** Increased by 4.9% . On a per-patient-day basis, total salaries, wages and benefits increased by 3.3% . - **Same-Facility Salaries, Wages and Benefits:** Increased by 3.7% . On a per-patient-day basis, same-facility salaries, wages and benefits increased by 2.0% . - **Interest Expense, net:** $38.330 million for Q1 2026 compared to $29.182 million for Q1 2025 . - **Transaction, Legal and Other Costs:** $22.013 million for Q1 2026 compared to $31.072 million for Q1 2025 . This included government investigations costs of $12.422 million for Q1 2026 compared to $31.011 million for Q1 2025 . - **Legal Settlements Expense:** $13.751 million for Q1 2026 compared to $3.504 million for Q1 2025 . #### Cash Flow - **Net Cash Provided by Operating Activities:** $61.531 million for Q1 2026 compared to $11.477 million for Q1 2025 . - **Net Cash Used in Investing Activities:** -$60.211 million for Q1 2026 compared to -$183.238 million for Q1 2025 . - **Net Cash Provided by Financing Activities:** $23.910 million for Q1 2026 compared to $186.692 million for Q1 2025 . #### Unique Metrics - **Same-Facility Revenue:** $813.384 million for Q1 2026, a 7.3% increase from $758.346 million for Q1 2025 . - **Same-Facility Patient Days:** 772,858 for Q1 2026, a 1.6% increase from 760,664 for Q1 2025 . - **Same-Facility Revenue per Patient Day:** $1,052 for Q1 2026, a 5.6% increase from $997 for Q1 2025 . - **Same-Facility Admissions:** 51,959 for Q1 2026, a 6.5% increase from 48,776 for Q1 2025 . - **Same-Facility Average Length of Stay:** 14.9 days for Q1 2026 compared to 15.6 days for Q1 2025, a -4.6% change . - **Total Facility Patient Days:** 786,780 for Q1 2026, a 1.5% increase from 774,933 for Q1 2025 . - **Total Facility Admissions:** 53,558 for Q1 2026, a 7.8% increase from 49,683 for Q1 2025 . - **Total Facility Average Length of Stay:** 14.7 days for Q1 2026 compared to 15.6 days for Q1 2025, a -5.8% change . - **Total Facility Revenue per Patient Day:** $1,053 for Q1 2026, a 5.9% increase from $994 for Q1 2025 . - **Newly Licensed Beds Added (Q1 2026):** 82 beds, including 42 beds to existing facilities and 40 beds from newly constructed facilities . - **Cash and Cash Equivalents (March 31, 2026):** $158.5 million . - **Available Revolving Credit Facility (March 31, 2026):** $564.8 million under its $1.0 billion facility . - **Net Leverage Ratio (March 31, 2026):** 3.9x Adjusted EBITDA . #### Outlook / Guidance Acadia Healthcare Company, Inc. projects Q2 2026 revenue between $835 million and $850 million, with Adjusted EBITDA expected to be in the range of $142 million to $152 million, including approximately $15 million in startup losses . For the full year 2026, the company maintained its revenue guidance of $3.37 billion to $3.45 billion, while increasing its Adjusted EBITDA guidance to $580 million to $615 million and operating cash flow to $285 million to $325 million . Capital expenditures remain unchanged at $255 million to $280 million, and the company anticipates year-end net leverage to be between 3.9x and 4.2x Adjusted EBITDA . ### Related Stocks - [ACHC.US](https://longbridge.com/en/quote/ACHC.US.md) ## Related News & Research - [Acadia names David M. Duckworth interim CFO as Todd Young resigns](https://longbridge.com/en/news/283888231.md) - [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md) - [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md) - [Acenta Group delays Q1 interim report release to May 29, 2026](https://longbridge.com/en/news/287031560.md) - [GDEV announces results for the first quarter of 2026 | GDEV Stock News](https://longbridge.com/en/news/286909689.md)